Your browser doesn't support javascript.
loading
A phase 3, open-label, single-arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis-stimulating agents.
Nangaku, Masaomi; Kondo, Kazuoki; Takabe, Souichirou; Ueta, Kiichiro; Tandai, Tsubasa; Kawaguchi, Yutaka; Komatsu, Yasuhiro.
Affiliation
  • Nangaku M; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kondo K; Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Takabe S; Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Ueta K; Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Tandai T; Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Kawaguchi Y; Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
  • Komatsu Y; Graduate School of Medicine, Gunma University, Maebashi, Gunma, Japan.
Ther Apher Dial ; 26(1): 45-54, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34115437
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Picolinic Acids / Renal Dialysis / Renal Insufficiency, Chronic / Glycine / Anemia Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Ther Apher Dial Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Picolinic Acids / Renal Dialysis / Renal Insufficiency, Chronic / Glycine / Anemia Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Ther Apher Dial Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Australia